Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese HSK 1 – For Medical Students & Physicians A complete 20-lesson, 300-page Chinese HSK 1 course with a companion app in 21 languages — free forever. Arabic, Bengali, Dutch, English, Farsi, French, German, Hindi, Indonesian, Italian, Japanese, Korean, Portuguese, Russian, Spanish, Tagalog, Thai, Turkish, Ukrainian, Urdu, Vietnamese. By Bernd Sebastian Kamps and Andrea Melis

Pulmonary Hypertension

Free Subscription 04.05.2026 1 Am J Physiol Lung Cell Mol Physiol 2 Br J Hosp Med (Lond) 1 Cell Mol Biol Lett 1 Chest 1 Circ Res 1 Clin Ter 2 Compr Physiol 1 Cureus 1 Curr Opin Pulm Med 1 Eur Heart J Qual Care Clin Outcomes 1 Front Bioeng Biotechnol 1 Front Biosci (Landmark Ed) 1 Front Cardiovasc Med 1 Front Immunol 1 Front Pharmacol 1 Heart 1 Heart Lung Circ 1 J Autoimmun 1 J Ethnopharmacol 1 JACC Cardiovasc Interv 1 JCI Insight 1 JHLT Open 1 Medicine (Baltimore) 1 PLoS One 1 Proc (Bayl Univ Med Cent) 3 Pulm Circ 1 Rev Esp Cardiol (Engl Ed) 1 Sci Rep 1 Turk J Med Sci 1 Zhong Nan Da Xue Xue Bao Yi Xue Ban

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Physiol Lung Cell Mol Physiol

1. ABU-SALEH D, Koshre GR, Piper B, Wang C, et al
   Global knockout of melanoma differentiation-associated protein 5 protects mice from chronic hypoxia/SU5416-induced pulmonary hypertension.
   Am J Physiol Lung Cell Mol Physiol. 2026 Apr 24. doi: 10.1152/ajplung.00299.2025
   PubMed         Abstract available
   
   

   
   Br J Hosp Med (Lond)

2. FORWARD C, McCullagh B, Gaine S, Quadery SR, et al
   Update on the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension: Diagnostic Imaging and Treatment Pathways in a New Era.
   Br J Hosp Med (Lond). 2026;87:53105.
   PubMed         Abstract available
   
   
3. GE D, Zhang Z
   Platelet-To-Lymphocyte Ratio and 28-Day Survival in Critically Ill Patients With Pulmonary Hypertension: Insights From a MIMIC-IV Retrospective Analysis.
   Br J Hosp Med (Lond). 2026;87:52966.
   PubMed         Abstract available
   
   

   
   Cell Mol Biol Lett

4. LU T, Jia W, Wang Y, Ma Y, et al
   Therapeutic potential of 20-Hydroxyecdysone in pulmonary arterial hypertension: involvement of Mas receptor and PI3K-Akt pathway.
   Cell Mol Biol Lett. 2026;31:70.
   PubMed         Abstract available
   
   

   
   Chest

5. GHIO S, Rapagnani A, Pasotti B, Alloni A, et al
   Risk stratification in chronic thromboembolic pulmonary hypertension patients after pulmonary endarterectomy. The role of brain natriuretic peptide and high-sensitivity troponin I.
   Chest. 2026 Apr 28:S0012-3692(26)00579-9. doi: 10.1016/j.chest.2026.
   PubMed         Abstract available
   
   

   
   Circ Res

6. DASGUPTA A, Chen KH, Wu D, Yerramilli VS, et al
   Dynamin 2 Regulates Mitochondrial Mitotic Fission in Pulmonary Hypertension.
   Circ Res. 2026 Apr 28. doi: 10.1161/CIRCRESAHA.125.327028.
   PubMed         Abstract available
   
   

   
   Clin Ter

7. ABDOU RM, El Wakeel MA, El-Kassas GM, Ali WH, et al
   Plasma Asymmetric Dimethylarginine as a Biomarker of Disease Severity and Therapeutic Response in Neonatal Persistent Pulmonary Hypertension: An Observational Prospective Case-Control Study.
   Clin Ter. 2026;177:539-548.
   PubMed         Abstract available
   
   

   
   Compr Physiol

8. AHMAD A, Zhang S, Ren Q, Li L, et al
   Integrating DeltaPCO(2) and Ca-vO(2) Into a Heart-Lung Coupling Index: A Novel Approach to Evaluate Cardiopulmonary Uncoupling in Pulmonary Arterial Hypertension.
   Compr Physiol. 2026;16:e70148.
   PubMed         Abstract available
   
   
9. JOSE A, Apewokin S, Ollberding NJ, Duan Q, et al
   Lactobacillus Is Associated With Disease in Pulmonary Arterial Hypertension: A Prospective Cohort Study.
   Compr Physiol. 2026;16:e70161.
   PubMed         Abstract available
   
   

   
   Cureus

10. BECERRIL PONCE A, Cota-Arce JM, Arenas-Lugo JA, Morales-Diaz LA, et al
    Chronic Thromboembolic Pulmonary Hypertension in a Patient With Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Case of Surgical Management With Pulmonary Endarterectomy.
    Cureus. 2026;18:e106075.
    PubMed         Abstract available
    
    

    
    Curr Opin Pulm Med

11. FORIS V, Cho MH, Boueiz A
    Genetic variants in pulmonary hypertension associated with chronic obstructive pulmonary disease.
    Curr Opin Pulm Med. 2026 Apr 28. doi: 10.1097/MCP.0000000000001275.
    PubMed         Abstract available
    
    

    
    Eur Heart J Qual Care Clin Outcomes

12. CONSTANTINE A, Dimopoulos K, Condliffe R, Clift P, et al
    Paediatric pulmonary arterial hypertension following congenital heart defect repair: enhanced risk stratification and outcomes in a national cohort.
    Eur Heart J Qual Care Clin Outcomes. 2026;12:325-335.
    PubMed         Abstract available
    
    

    
    Front Bioeng Biotechnol

13. LIU Q, Zhao Y, Jiang Z, Lu H, et al
    Preoperative of balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension using virtual balloon expansion: a pilot study.
    Front Bioeng Biotechnol. 2026;14:1741437.
    PubMed         Abstract available
    
    

    
    Front Biosci (Landmark Ed)

14. LUO J, Chang J, Liu Y, Shao Y, et al
    NDRG2 Drives DRP1 Phosphorylation to Promote the Progression of Pulmonary Hypertension.
    Front Biosci (Landmark Ed). 2026;31:48054.
    PubMed         Abstract available
    
    

    
    Front Cardiovasc Med

15. DAI T, Liu B, Zhao Q, Li X, et al
    Risk factors for different types of arrhythmias and their prognostic impact in patients with heart failure and concomitant pulmonary hypertension (PH-LHF): a large-scale retrospective cohort study.
    Front Cardiovasc Med. 2026;13:1773989.
    PubMed         Abstract available
    
    

    
    Front Immunol

16. YANG Y, Lei Y, Wu B, Ning K, et al
    Integrative single-cell RNA-seq and ATAC-seq analysis reveals the key role of inflammatory cell activation in pulmonary arterial hypertension.
    Front Immunol. 2026;17:1796116.
    PubMed         Abstract available
    
    

    
    Front Pharmacol

17. GAO L, Wu Q, Li X, Long Y, et al
    Baicalin-geniposide attenuates pulmonary inflammation and vascular injury via HMGB1 blockade: insights from a cerebral ischemia-reperfusion model and implications for pulmonary hypertension.
    Front Pharmacol. 2026;17:1822890.
    PubMed         Abstract available
    
    

    
    Heart

18. CAI Y, Tang H, Wei X
    Pulmonary hypertension after atrial septal defect repair.
    Heart. 2026;112:583-584.
    PubMed        
    
    

    
    Heart Lung Circ

19. PENTIKAINEN MO, Heliovaara E, Halme M, Rasanen J, et al
    Chronic Thromboembolic Pulmonary Hypertension in Patients With Thoracic Outlet Syndrome-Association With Younger Age and More Distal Disease.
    Heart Lung Circ. 2026 Apr 29:S1443-9506(26)00050.
    PubMed         Abstract available
    
    

    
    J Autoimmun

20. KAS F, Elhai M, Becker MO, Dobrota R, et al
    Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database.
    J Autoimmun. 2026;160:103555.
    PubMed         Abstract available
    
    

    
    J Ethnopharmacol

21. ZHANG Y, Zeng M, Guo P, Zhang Z, et al
    Effects of Rehmannia glutinosa Libosch. Rhizome water extract and Rehmapicrogenin on pulmonary hypertension: Multi-omics insights into epidermal growth factor receptor/pyruvate kinase M2 pathway and metabolic regulation.
    J Ethnopharmacol. 2026;367:121775.
    PubMed         Abstract available
    
    

    
    JACC Cardiovasc Interv

22. AUGER WR, Krasuski RA, Mahmud E, Leary PJ, et al
    Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension: Statement From the BPA-CTEPH Alliance.
    JACC Cardiovasc Interv. 2026;19:923-942.
    PubMed         Abstract available
    
    

    
    JCI Insight

23. STEFFES LC, Chiles KA, Masud SR, Rahman A, et al
    Excessive Postnatal Smooth Muscle Differentiation in a Lung Specific Model of TBX4-related Pulmonary Hypertension.
    JCI Insight. 2026 Apr 23:e194251. doi: 10.1172/jci.insight.194251.
    PubMed         Abstract available
    
    

    
    JHLT Open

24. MELENDRES-GROVES L, Perez VJ, Vaidya A, Lee HG, et al
    Qualitative interviews of patients with methamphetamine-associated pulmonary hypertension: Understanding the unmet medical need from the patient lens.
    JHLT Open. 2026;13:100549.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

25. CUI X, Zhong Y, Yin C
    A child with cobalamin C deficiency caused by complex heterozygous variation of c.567dupT and c.80A > G complicated with pulmonary arterial hypertension and hydrocephalus: A case report and literature review.
    Medicine (Baltimore). 2026;105:e48340.
    PubMed         Abstract available
    
    

    
    PLoS One

26. TOMONAGA Y, Lichtblau M, Ulrich S, Guler SA, et al
    Economic burden of pulmonary arterial hypertension in Switzerland.
    PLoS One. 2026;21:e0348190.
    PubMed         Abstract available
    
    

    
    Proc (Bayl Univ Med Cent)

27. HOCKING J, Felder A, Connelly M, Dudek T, et al
    Early experience with chronic thromboembolic pulmonary hypertension in patients undergoing structured follow-up after Pulmonary Embolism Response Team evaluation.
    Proc (Bayl Univ Med Cent). 2026;39:425-430.
    PubMed         Abstract available
    
    

    
    Pulm Circ

28. PARVATHANENI K, Kochanski JJ, Tandel MD, Liu E, et al
    Treprostinil Is Associated With Early and Sustained Improvement in Group 3 Pulmonary Hypertension and Right Ventricular Function in Children.
    Pulm Circ. 2026;16:e70304.
    PubMed         Abstract available
    
    
29. COLON HIDALGO D, Lewis CV, Nguyen TN, Posey JN, et al
    R213G-Mediated Redistribution of EC-SOD Protects Against Sugen-Hypoxia Pulmonary Hypertension in Mice.
    Pulm Circ. 2026;16:e70307.
    PubMed         Abstract available
    
    
30. MCCORMACK C, Hardcastle SJ, Moyna NM, Morahan E, et al
    Flexible, Accessible, Effective: Patient Perceptions of the Pulmonary Hypertension and Home-Based (PHAHB) Physical Activity Intervention.
    Pulm Circ. 2026;16:e70309.
    PubMed         Abstract available
    
    

    
    Rev Esp Cardiol (Engl Ed)

31. PLAYAN-ESCRIBANO J, Labrandero de Lera C, Albert de la Torre L, Rodriguez-Ogando A, et al
    Adapting the REVEAL Lite 2 score to the pediatric population through machine learning: insights from the REHIPED registry for pediatric pulmonary hypertension.
    Rev Esp Cardiol (Engl Ed). 2026 Apr 23:S1885-5857(26)00074.
    PubMed         Abstract available
    
    

    
    Sci Rep

32. WALIGORA M, Zaczynska K, Stepniewski J, Lis E, et al
    Electrocardiographic signs to differentiate between chronic thromboembolic pulmonary hypertension and intermediate-high risk acute pulmonary embolism.
    Sci Rep. 2026 Apr 25. doi: 10.1038/s41598-026-48092.
    PubMed        
    
    

    
    Turk J Med Sci

33. ERDAG M, Caliskan T, Yildirim H, Kivrak T, et al
    Retinal microvascular and neuroretinal structural changes in pulmonary arterial hypertension assessed by OCTA: a comparative study.
    Turk J Med Sci. 2026;56:471-478.
    PubMed         Abstract available
    
    

    
    Zhong Nan Da Xue Xue Bao Yi Xue Ban

34. XIE Y, Tan Y, Li J
    [Role of echocardiography in the assessment of right ventricular function in pulmonary hypertension].
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2026;51:150-157.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum